Perrigo (PRGO) is up 1.7% after announcing it has filed for a new drug application with the FDA for its Androgel testosterone gel, which currently generates $900M in annual worldwide sales. However, Perrigo adds that Abbott (ABT) has filed a patent infringement suit against it over the product.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at CNBC.com (Dec 30, 2014)
at Benzinga.com (Dec 23, 2014)
at CNBC.com (Nov 6, 2014)
at MarketWatch.com (Sep 29, 2014)
at CNBC.com (Aug 29, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs